IJSDR
IJSDR
INTERNATIONAL JOURNAL OF SCIENTIFIC DEVELOPMENT AND RESEARCH
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2455-2631 | Impact factor: 8.15 | ESTD Year: 2016
open access , Peer-reviewed, and Refereed Journals, Impact factor 8.15

Issue: May 2024

Volume 9 | Issue 5

Impact factor: 8.15

Click Here For more Info

Imp Links for Author
Imp Links for Reviewer
Research Area
Subscribe IJSDR
Visitor Counter

Copyright Infringement Claims
Indexing Partner
Published Paper Details
Paper Title: An overview on Adverse drug reactions (ADR) and its biomarkers
Authors Name: Mr Basharat Nawaz , Mr. Mohd Razi
Unique Id: IJSDR2302144
Published In: Volume 8 Issue 2, February-2023
Abstract: Adverse drug reactions (ADR) are a significant public health issue for both individuals and society. In developed nations, adverse drug reactions (ADRs) are among the top 10 leading causes of illness and death. ADRs are a public health issue though since they cause 5- 10% of hospitalizations and lengthen hospital stays . ADRs are between the fourth and sixth most common causes of death in some nations. Factors contributing to adverse drug reactions are age, sex, polypharmacy, pharmacogenetics, previous exposure etc. ADRs are classified into various categories depending upon their effect. Scales specifically designed for the identification of an ADR which includes Naranjo Scale Development,The WHO-UMC causality assessment system,Hartwig’s Severity Assessment Scale. . Adverse drug reactions also represent a financial burden to both healthcare providers and the pharmaceutical industry. Thus, a number of stakeholders would benefit from development of new, robust biomarkers for the prediction, diagnosis, and prognostication of adverse drug reactions. There has been significant recent progress in identifying predictive genomic biomarkers with the potential to be used in clinical settings to reduce the burden of adverse drug reactions. These have included biomarkers that can be used to alter drug dose (for example, Thiopurine methyltransferase (TPMT) and azathi oprine dose) and drug choice. The latter have in particular included human leukocyte anti gen (HLA) biomarkers which identify susceptibility to immune-mediated injuries to major organs such as skin, liver, and bone marrow from a variety of drugs.
Keywords: Adverse drug reactions, prognostication, pharmacogenomics, biomarkers, human leukocyte antigen.
Cite Article: "An overview on Adverse drug reactions (ADR) and its biomarkers", International Journal of Science & Engineering Development Research (www.ijsdr.org), ISSN:2455-2631, Vol.8, Issue 2, page no.824 - 841, February-2023, Available :http://www.ijsdr.org/papers/IJSDR2302144.pdf
Downloads: 000338719
Publication Details: Published Paper ID: IJSDR2302144
Registration ID:204168
Published In: Volume 8 Issue 2, February-2023
DOI (Digital Object Identifier):
Page No: 824 - 841
Publisher: IJSDR | www.ijsdr.org
ISSN Number: 2455-2631

Click Here to Download This Article

Article Preview

Click here for Article Preview







Major Indexing from www.ijsdr.org
Google Scholar ResearcherID Thomson Reuters Mendeley : reference manager Academia.edu
arXiv.org : cornell university library Research Gate CiteSeerX DOAJ : Directory of Open Access Journals
DRJI Index Copernicus International Scribd DocStoc

Track Paper
Important Links
Conference Proposal
ISSN
DOI (A digital object identifier)


Providing A digital object identifier by DOI
How to GET DOI and Hard Copy Related
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Creative Commons License
This material is Open Knowledge
This material is Open Data
This material is Open Content
Social Media
IJSDR

Indexing Partner